Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy
Charcot-Marie-Tooth disease 1A (CMT1A) is a peripheral demyelinating disease. Here, the authors demonstrate in a rodent model of CMT1A that Schwann cells have impairments in lipid biosynthesis, and that restoring lipids via diet can reverse the dysmyelinating phenotype in these animals.
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
02 August 2018
|
| In: |
Nature Communications
Year: 2018, Volume: 9, Pages: 1-14 |
| ISSN: | 2041-1723 |
| DOI: | 10.1038/s41467-018-05420-0 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/s41467-018-05420-0 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/s41467-018-05420-0 |
| Author Notes: | R. Fledrich, T. Abdelaal, L. Rasch, V. Bansal, V. Schütza, B. Brügger, C. Lüchtenborg, T. Prukop, J. Stenzel, R.U. Rahman, D. Hermes, D. Ewers, W. Möbius, T. Ruhwedel, I. Katona, J. Weis, D. Klein, R. Martini, W. Brück, W.C. Müller, S. Bonn, I. Bechmann, K.A. Nave, R.M. Stassart and M.W. Sereda |
| Summary: | Charcot-Marie-Tooth disease 1A (CMT1A) is a peripheral demyelinating disease. Here, the authors demonstrate in a rodent model of CMT1A that Schwann cells have impairments in lipid biosynthesis, and that restoring lipids via diet can reverse the dysmyelinating phenotype in these animals. |
|---|---|
| Item Description: | Gesehen am 22.04.2020 |
| Physical Description: | Online Resource |
| ISSN: | 2041-1723 |
| DOI: | 10.1038/s41467-018-05420-0 |